Biological predictors of response to antidepressants
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Escitalopram (Primary) ; Desipramine
- Indications Major depressive disorder
- Focus Biomarker; Therapeutic Use
- 04 Apr 2012 Additional lead trial centre (New York State Psychiatric Institute) added as reported by ClinicalTrials.gov.
- 04 Apr 2012 Planned end date changed from 1 Sep 2011 to 1 May 2012 as reported by ClinicalTrials.gov.
- 22 Oct 2008 Planned end date is 1 Sep 2011.